Industry News

Industry News

Issue III Registry Defines Best Syncope Candidates For Cardiac Pacing

Jun 28, 2013

Two important studies were released at the Late Breaking Clinical Trials session II at EHRA EUROPACE 2013. The PREFER AF study found that Oral anticoagulation is now used in over 85% of patients with atrial fibrillation (AF) eligible for therapy... Read More

Aggressive Prostate Cancers In Black Men May Be Missed During 'Active Surveillance'

Jun 28, 2013

A Johns Hopkins study of more than 1,800 men ages 52 to 62 suggests that African-Americans diagnosed with very-low-risk prostate cancers are much more likely than white men to actually have aggressive disease that goes unrecognized with current diagnostic approaches... Read More

First Large-Scale Comparison Shows Human And Canine Lymphomas Share Molecular Similarities

Jun 28, 2013

Humans and their pet dogs are close, so close that they both develop a type of cancer called diffuse large B-cell lymphoma. In humans it's the most common lymphoma subtype while in dogs, it's one of the most common cancers in veterinary oncology... Read More

Care Of Limited-Stage Small-Cell Lung Cancer Patients Improved By PET-CT

Jun 28, 2013

Each year, 13 percent of all newly diagnosed lung cancer patients are diagnosed with small-cell lung cancer (SCLC). Approximately 39 percent of patients with SCLC are diagnosed with limited-stage disease, meaning the cancer is only present in one lung, but may have spread to lymph nodes or tissue between the lungs... Read More

More Research Needed On Treatment For Lung Cancer In Female 'Never Smokers'

Jun 28, 2013

The incidence of lung cancer in women affects an estimated 516,000 women worldwide, of which 100,000 are in the United States and 70,000 in Europe. Until now, lung cancers occurring in women have been treated similarly to lung cancers in men. However, numerous studies have highlighted different characteristics of lung cancer in women... Read More

Immunohistochemistry Could Be A Reliable And Cost-Effective Diagnostic Approach In Lung Cancer

Jun 28, 2013

ALK rearrangement has been demonstrated to be a potent oncogenic driver and a promising therapeutic target in non-small cell lung cancer (NSCLC). It defines a distinct molecular subset of NSCLC, in particular adenocarcinoma that can benefit by the treatment of ALK-inhibitors... Read More

Cancer-Promoting Mechanisms Of Overlooked Components In Secondhand Smoke

Jun 28, 2013

Tobacco smoke, diesel exhaust and oil combustion carry polycyclic aromatic hydrocarbons - PAHs that are known to cause cancer. But of these PAHs, the obviously dangerous high-molecular-weight PAHs like benzo[a]pyrene (BaP) have received the vast majority of research attention... Read More

Prototype Device Aims To Avert Repeated Breast Cancer Surgeries

Jun 28, 2013

When a breast tumor is detected, many women opt to have a lumpectomy, which is surgery designed to remove the diseased tissue while preserving the breast. But during this procedure, doctors cannot learn right away whether all of the cancerous tissue has been removed, with no microscopic signs that cancer cells were left behind... Read More

FDA Approves Hemophilia B Drug "Rixubis"

Jun 28, 2013

The FDA has just approved the drug Rixubis [Coagulation Factor IX (Recombinant)] for people over the age of 16 suffering from hemophilia B. Hemophilia B is an inherited chronic blood disorder where the blood does not clot properly, it is caused by mutations in the Factor IX gene. The symptoms of hemophilia are characterized by serious bleeding (particularly in the joints) and easy bruising... Read More

Small Proteins Unique To Melanoma Cells Rapidly Identified By New Screening Approach

Jun 27, 2013

Jamie K. Teer, Ph.D., assistant member of the Cancer Biology and Evolution Program at Moffitt Cancer Center, and colleagues have developed a new streamlined method to rapidly identify the genetic changes in small protein fragments unique to melanoma cancer cells. These fragments can be used as targets for tumor-infiltrating lymphocytes that have been shown to reduce cancerous lesions... Read More

Previous Page   Next Page